-
公开(公告)号:MX2017002333A
公开(公告)日:2017-08-28
申请号:MX2017002333
申请日:2015-08-21
Applicant: ACADEMIA SINICA
Inventor: HSIN-YU LEE , CHUNG-YI WU , CHI-HUEY WONG
Abstract: Esta divulgación incluye una composición inmunogenica que contiene (a) a un conjunto de glicano que incluye un portador y uno o más glicanos, en donde cada uno de los uno o más glicanos se conjugan con el portador mediante un enlazador, y opcionalmente (b) un adyuvante. Los uno o más glicanos son cada uno un derivado de Globo H.
-
公开(公告)号:IL264873B2
公开(公告)日:2023-08-01
申请号:IL26487319
申请日:2019-02-17
Applicant: CHO PHARMA INC , ACADEMIA SINICA , LIN NAN HORNG , LIN YA HUANG , SACHIN S SHIVATARE , LI TZU CHEN , CHI HUEY WONG , CHUNG YI WU , TING CHENG
Inventor: LIN NAN-HORNG , LIN-YA HUANG , SACHIN S SHIVATARE , LI-TZU CHEN , CHI-HUEY WONG , CHUNG-YI WU , TING CHENG
Abstract: A mutant of EndoS2 includes one or more mutations in the sequence of a wild-type EndoS2 (SEQ ID NO:1), wherein the one or more mutations are in a peptide region located within residues 133-143, residues 177-182, residues 184-189, residues 221-231, and/or residues 227-237, wherein the mutant of EndoS2 has a low hydrolyzing activity and a high tranglycosylation activity, as compared to those of the wild-type EndoS2. A method for preparing an engineered glycoprotein using the mutant of EndoS2 includes coupling an activated oligosaccharide to a glycoprotein acceptor. The activated oligosaccharide is a glycan oxazoline.
-
公开(公告)号:IL293502A
公开(公告)日:2022-08-01
申请号:IL29350222
申请日:2022-06-01
Applicant: ACADEMIA SINICA , CHI HUEY WONG , CHUNG YI WU
Inventor: CHI-HUEY WONG , CHUNG-YI WU
IPC: F27D11/08
Abstract: Immunogenic compositions comprising hemagglutinin (HA) variants and/or neuraminidase (NA) variants, which may be contained in an influenza A virus, and uses thereof for eliciting immune responses against influenza A virus.
-
公开(公告)号:IL266526D0
公开(公告)日:2019-07-31
申请号:IL26652619
申请日:2019-05-08
Applicant: CHI HUEY WONG , ACADEMIA SINICA , CHUNG YI WU
Inventor: CHI-HUEY WONG , CHUNG-YI WU
IPC: F27D20060101
Abstract: Immunogenic compositions comprising hemagglutinin (HA) variants and/or neuraminidase (NA) variants, which may be contained in an influenza A virus, and uses thereof for eliciting immune responses against influenza A virus.
-
-
-